3亿元融资！微元合成加速推进甲醇生物制造大宗生物基产品

Core Viewpoint - The article emphasizes the importance of "non-grain" raw materials in the future of the bio-manufacturing industry, highlighting the recent funding round of nearly 300 million yuan for Weiyuan Synthesis to accelerate the development of methanol-based bio-manufactured products [2][3]. Group 1: Industry Trends - The bio-manufacturing sector is positioned as a key driver for future industrial transformation, with McKinsey predicting that 60% of global material production could be synthesized biologically [2]. - The current reliance on starch sugars for bio-based products poses a risk of "competing with food" due to the high demand for agricultural resources, which contradicts the goals of sustainable development [2][3]. Group 2: Methanol Production and Capacity - China's methanol production capacity has rapidly expanded, exceeding 100 million tons, with an additional 100 million tons planned, primarily from coal, which accounts for 80% of production [4][5]. - The development of green methanol production using renewable energy sources is gaining traction, with plans for 6 million tons of green methanol capacity by mid-2025, which could support the bio-manufacturing sector and contribute to carbon neutrality goals [5]. Group 3: Weiyuan Synthesis Developments - Weiyuan Synthesis has successfully developed high-efficiency strains for assimilating methanol and is advancing its pipeline for bio-manufactured products, including bulk amino acids and bio-based materials [7]. - This innovation addresses the raw material challenges in bio-manufacturing and helps mitigate the domestic surplus of methanol, while also reducing reliance on imported soybean meal, thereby enhancing food security [7].